Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist)

British Journal of Radiology

Volumn 71, Issue 850, 1998, Pages 1026-1032

  Uggowitzer, M ^a,b   Kugler, C ^a   Groll R ^a   Mischinger, H J ^a   Stacher, R ^a   Fickert, P ^a   Weiglein, A ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ECHO CONTRAST MEDIUM; GALACTOSE; SHU 508;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; HEPATIC ARTERY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER HYPERPLASIA; NODULAR HYPERPLASIA; RESISTANCE BLOOD VESSEL; SIGNAL NOISE RATIO; VASCULARIZATION;

ADULT; CONTRAST MEDIA; FEMALE; HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; MIDDLE AGED; POLYSACCHARIDES; ULTRASONOGRAPHY, DOPPLER;

EID: 0031693819     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.71.850.10211062     Document Type: Article

References (18)

1. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194-200.
2. Whelan TJ, Baugh JH, Chandor S. Focal nodular hyperplasia of the liver. Ann Surg 1973;177:150-8.
3. Knowles DM, Wolff M. Focal nodular hyperplasia of the liver: A clinicopathologic study and review of the literature. Hum Pathol 1976;7:533-45.
4. Shamsi K, De Schepper A, DeGryse H, Deckers F. Focal nodular hyperplasia of the liver: CT and sonographic spectrum. Abdom Imaging 1993;18:32-8.
5. Rummeny E, Weissleder R, Sironi S, Stark DD, Compton C, Hahn PS, et al. Central scars in primary liver tumours: MR features specificity and pathologic correlation. Radiology 1989;171:323-6.
6. Schwarz KQ, Becher H, Schimpfky C, Vorwerk D, Bogdhan U, Schlief R. Doppler enhancement with SHU 508A in multiple vascular regions. Radiology 1994;193:195-201.
7. Fujimoto M, Moriyasu F, Nishikawa Y, Nada T, Okuma M. Colour Doppler sonography of hepatic tumours with a galactose-based contrast agent: Correlation with angiographic findings. AJR 1994;163:1099-104.
8. Rosenkranz K, Zendel W, Langer R, Heim T, Schubeus P, Scholz A, et al. Contrast-enhanced transcranial Doppler US with a new transpulmonary echo contrast agent based on saccharide microparticles. Radiology 1993;187:439-43.
9. Schlief R, Schürmann R, Balzer T, Zomak M, Niendorf HP. Saccharide based contrast agent. In: Nanda NC, Schlief R, editors. Advances in echo imaging using contrast enhancement. Dordrecht: Kluwer Academic Publishers, 1993:71-96.
10. Uggowitzer M, Kugler C, Machan L, Gröll R, Stauber R, Mischinger HJ, et al. Power Doppler imaging and evaluation of the resistive index in focal nodular hyperplasia of the liver. Abdom Imaging 1997;22:268-73.
11. Coinaud C. Le foie: etudes anatomiques et chirudicales. Paris: Masson, 1957.
12. Mahfouz AE, Hamm B, Taupitz M, Wolf KJ. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia malignant tumours with the dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:133-8.
13. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N. Hepatic adenoma and focular nodular hyperplasia; dynamic CT study. Radiology 1986;160:53-8.
14. Yamashita Y, Hatanaka Y, Yamamoto H, Arakawa A, Matsukawa T, Miyazaki T, et al. Differential diagnosis of focal liver lesions: Role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology 1994;193:59-65.
15. Takayasu K, Muramatsu Y, Moriyama N, Yamazaki S, Takayama T, Hirohashi S, et al. Focal nodular hyperplasia of the liver: Arterial angio-CT and microangiopathy. JCAT 1992;16:212-5.
16. Caiati C, Schlief R, Aragona PL, Sublimi L, Rizzon P. Enhanced Doppler signal intensity in coronary artery after intravenous injection of lung crossing echocontrast agent [SHU 508A]. J Am Coll Cardiol 1992;19:323.
17. Bogdhan U, Becker G, Schlief R, Redding J, Hassel W. Contrast-enhanced transcranial colour-coded real-time sonography. Results of phase two study. Stroke 1993;24:676-84.
18. Schroeder K, Voeller H, Agrawaj R, Schlief R, Schroeder R. Improved border delineation in suboptimal stress echocardiography by the new left heart contrast agent Shu 508A. J Am Coll Cardiol 1992;19:175.